Meth bill
This article was originally published in The Tan Sheet
Executive Summary
Legislation limiting retail sales of pseudoephedrine-containing OTCs to 9 g per purchase introduced July 19 by Sens. Dianne Feinstein (D-Calif.), Tim Hutchinson (R-Ark.) and Herb Kohl (D-Wisc.). Provision "to close the 'blister pack loophole' would make it harder for methamphetamine manufacturers to obtain large quantities" of precursor ephedrine, Hutchinson says in same-day 1press release announcing bill. S 2763 "will still allow consumers to purchase weeks or months worth of cold medicine at once, but will prevent large-scale purchases by meth dealers," Feinstein adds. Bill would provide $125.5 mil. to fund cleanup of meth labs, train law enforcement agents to prosecute meth offenses. Rep. Doug Ose (R-Calif.) has introduced similar legislation in the House (2"The Tan Sheet" Feb. 25, 2002, In Brief)...
You may also be interested in...
Pseudoephedrine Retail Purchase Uniform 9 Gram Threshold Proposed In Bill
Retail purchases of "combination ephedrine products" would be limited to 9 g per transaction by legislation introduced in the Senate to curb the illegal production and distribution of methamphetamines
Meth bill
Congress "strongly urges" President Bush to approach Canadian government to immediately "stem the widespread and increasing availability in Canada and the illegal importation into the U.S. of pseudoephedrine," according to House bill introduced Feb. 14. HR 3782, introduced by Rep. Doug Ose (R-Calif.) and 22 co-sponsors notes Canada lacks legislative framework to counter the drug's trafficking. Legislation, which addresses illegal production, distribution, use of meth, was referred to the Commerce, Agriculture, Education, Judiciary committees. Similar concurrent resolution was introduced in House Feb. 6 (1"The Tan Sheet" Feb. 11, 2002, In Brief)...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.